LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,000 | +42.9% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $7,000 | -30.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $10,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $10,000 | -9.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $11,000 | -91.6% | 100 | -89.6% | 0.00% | -96.3% |
| Q4 2018 | $131,000 | +47.2% | 962 | +196.0% | 0.03% | -34.1% |
| Q3 2018 | $89,000 | +23.6% | 325 | -35.0% | 0.04% | +105.0% |
| Q3 2017 | $72,000 | -99.9% | 500 | 0.0% | 0.02% | +33.3% |
| Q2 2017 | $61,000,000 | +8.9% | 500 | 0.0% | 0.02% | -6.2% |
| Q1 2017 | $56,000,000 | +9.8% | 500 | 0.0% | 0.02% | +77.8% |
| Q4 2016 | $51,000,000 | +99900.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $51,000 | -13.6% | 500 | 0.0% | 0.01% | -52.6% |
| Q2 2016 | $59,000 | +11.3% | 500 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $53,000 | -1.9% | 500 | 0.0% | 0.02% | -5.0% |
| Q4 2015 | $54,000 | – | 500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |